The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of acute myeloid leukemia (AML) and solid tumors.
 
Aparajita Hoskote Chourasia
Employment - BioTheryX
Stock and Other Ownership Interests - BioTheryX
Consulting or Advisory Role - NovoMedix
Research Funding - BioTheryX
Patents, Royalties, Other Intellectual Property - BioTheryX
 
Hannah Majeski
No Relationships to Disclose
 
Angela Pasis
No Relationships to Disclose
 
Paul Erdman
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb; Pfizer
 
Ashwini Oke
No Relationships to Disclose
 
David Hecht
Employment - BioTheryX (I)
Stock and Other Ownership Interests - BioTheryX; BioTheryX (I); NovoMedix; NovoMedix (I)
Consulting or Advisory Role - BioTheryX; NovoMedix
Patents, Royalties, Other Intellectual Property - BioTheryX; San Diego State University
 
David Lonergan
Stock and Other Ownership Interests - Gilead Sciences
Patents, Royalties, Other Intellectual Property - Pharmakea
 
Frank Mercurio
Employment - BioTheryX
Stock and Other Ownership Interests - BioTheryX
Research Funding - BioTheryX
 
Kyle Chan
Employment - BioTheryX
Leadership - BioTheryX
Stock and Other Ownership Interests - BioTheryX
Patents, Royalties, Other Intellectual Property - BioTheryX
 
Dung Luong Thai
Employment - BioTheryX; REMD Biotherapeutics
Leadership - BioTheryX; REMD Biotherapeutics
Stock and Other Ownership Interests - BioTheryX; REMD Biotherapeutics
Consulting or Advisory Role - Amphivena; Arch Oncology; AskGene; Binacea; Five Prime Therapeutics; Gilead Sciences; QR Management; Zenshine
 
Leah Fung
Employment - BioTheryX
Leadership - BioTheryX
Stock and Other Ownership Interests - BioTheryX
Consulting or Advisory Role - BioTheryX
Research Funding - BioTheryX
Patents, Royalties, Other Intellectual Property - BioTheryX
Travel, Accommodations, Expenses - BioTheryX
Other Relationship - NovoMedix
(OPTIONAL) Uncompensated Relationships - NovoMedix